↓ Skip to main content

Dove Medical Press

Article Metrics

Traumeel – an emerging option to nonsteroidal anti-inflammatory drugs in the management of acute musculoskeletal injuries

Overview of attention for article published in International Journal of General Medicine, March 2011
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#32 of 1,295)
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter
36 tweeters
patent
2 patents
facebook
19 Facebook pages
googleplus
6 Google+ users
reddit
1 Redditor

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
102 Mendeley
Title
Traumeel – an emerging option to nonsteroidal anti-inflammatory drugs in the management of acute musculoskeletal injuries
Published in
International Journal of General Medicine, March 2011
DOI 10.2147/ijgm.s16709
Pubmed ID
Authors

Christian Schneider

Abstract

Musculoskeletal injuries are on the rise. First-line management of such injuries usually employs the RICE (rest, ice, compression, and elevation) approach to limit excessive inflammation. Nonsteroidal anti-inflammatory drugs (NSAIDs) are also commonly used to limit inflammation and to control pain. Traumeel(®), a preparation with bioregulatory effects is also used to treat the symptoms associated with acute musculoskeletal injuries, including pain and swelling. Traumeel is a fixed combination of biological and mineral extracts, which aims to apply stimuli to multiple targets to restore normal functioning of regulatory mechanisms. This paper presents the accumulating evidence of Traumeel's action on the inflammatory process, and of its efficacy and tolerability in randomized trials, as well as observational and surveillance studies for the treatment of musculoskeletal injuries. Traumeel has shown comparable effectiveness to NSAIDs in terms of reducing symptoms of inflammation, accelerating recovery, and improving mobility, with a favorable safety profile. While continued research and development is ongoing to broaden the clinical evidence of Traumeel in acute musculoskeletal injury and to further establish its benefits, current information suggests that Traumeel may be considered as an anti-inflammatory agent that is at least as effective and appears to be better tolerated than NSAIDs.

Twitter Demographics

The data shown below were collected from the profiles of 36 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 102 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 2 2%
Colombia 1 <1%
Australia 1 <1%
Spain 1 <1%
United States 1 <1%
Unknown 96 94%

Demographic breakdown

Readers by professional status Count As %
Student > Master 22 22%
Researcher 19 19%
Student > Bachelor 10 10%
Other 8 8%
Student > Postgraduate 7 7%
Other 22 22%
Unknown 14 14%
Readers by discipline Count As %
Medicine and Dentistry 45 44%
Agricultural and Biological Sciences 13 13%
Nursing and Health Professions 6 6%
Biochemistry, Genetics and Molecular Biology 5 5%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Other 15 15%
Unknown 14 14%

Attention Score in Context

This research output has an Altmetric Attention Score of 48. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 April 2022.
All research outputs
#676,095
of 21,546,712 outputs
Outputs from International Journal of General Medicine
#32
of 1,295 outputs
Outputs of similar age
#3,471
of 144,317 outputs
Outputs of similar age from International Journal of General Medicine
#4
of 39 outputs
Altmetric has tracked 21,546,712 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,295 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 144,317 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 39 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.